SecBot SecBot
144 ·Filed Apr 10, 2026

LQDA

Liquidia Corp
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001950047-26-003385
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for actual execution of the sale; 10b5-1 plans are pre-arranged and not necessarily indicative of negative sentiment, but large insider transactions should be tracked in context of broader activity. Recent insider selling totals $4.0M over the past 30 days, suggesting ongoing portfolio management rather than isolated action.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
LQDA ▲ +104.56% at T+60d
NEUTRAL call +104.56% · α vs SPY +95.63% · entry $38.85 → $79.47
Entry = T+0 close
Apr 10, 2026
via day close
T+1d
-0.36%
call -0.36% · α -1.57%
$38.71
settled 7mo ago
T+5d
-3.06%
call -3.06% · α -6.36%
$37.66
settled 6mo ago
T+20d
+36.76%
call +36.76% · α +29.03%
$53.13
settled 6mo ago
T+60d
+104.56%
call +104.56% · α +95.63%
$79.47
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Roger Jeffs, a director and officer of Liquidia Corp, filed a Form 144 to notify intent to sell 25,000 shares of common stock, valued at approximately $1.008 million. The sale is part of a 10b5-1 plan under Serendipity Biopharma LLC, his affiliated entity.

Key Facts

  • Roger Jeffs, Director and Officer of Liquidia Corp, is the reporting owner.
  • Filed Form 144 for 25,000 shares of common stock.
  • Approximate sale value: $1,008,000 (based on $40.32/share).
  • Sale is conducted under a 10b5-1 plan by Serendipity Biopharma LLC, an affiliate of Jeffs.
  • Shares to be sold on or after April 10, 2026, on NASDAQ.

Financial Impact

$1.008 million in proposed sales from a $3.6B market cap company

dilutioninsider ownership

Risk Factors

  • Potential perception of insider selling pressure, especially given prior transactions by the same entity.
  • Execution of the sale could contribute to near-term trading volume and minor price pressure.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-003385
Document: 0001950047-26-003385-index.html0001950047-26-003385
Document: 0001950047-26-003385.txt0001950047-26-003385
45 reports for LQDA
Performance horizon
57% Hit rate @ T+1 12 of 21 directional calls Went positive at some point 15 of 21 best @ T+60▲ +70.18%Mar 5, 2026
Filters
Rows
Reports for LQDA — sortable, filterable
TypeNow
Oct 13, 2026
12d ago
8-K
MIXED ★ 7/10
$33.94 $34.78▲ +2.48%▲ +2.19%$43.74 (+28.87%)
Oct 13, 2026
12d ago
Insider Cluster
NEUTRAL ★ 4/10
$33.94 $34.78▲ +2.48%▲ +2.19%$43.74 (+28.87%)
Sep 30, 2026
25d ago
8-K
BEARISH ★ 7/10
$27.99 $28.64▼ −2.32%▼ −1.58%$43.74 (−56.27%)
Sep 3, 2026
7w ago
8-K
BULLISH ★ 5/10
$68.63 $68.66▲ +0.04%▲ +0.43%$43.74 (−36.27%)
Sep 3, 2026
7w ago
Press Release
BULLISH ★ 6/10
$68.63 $68.66▲ +0.04%▲ +0.43%$43.74 (−36.27%)
Aug 25, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$71.36 $69.94▼ −1.99%▼ −2.65%$43.74 (−38.71%)
Aug 21, 2026
9w ago
Insider Cluster
NEUTRAL ★ 4/10
$70.27 $70.49▲ +0.31%▼ −0.01%$43.74 (−37.75%)
Aug 12, 2026
10w ago
8-K
BULLISH ★ 6/10
$78.79 $72.10▼ −8.49%▼ −9.19%$43.74 (−44.49%)
Aug 12, 2026
10w ago
Press Release
BEARISH ★ 6/10
$78.79 $72.10▲ +8.49%▲ +9.19%$43.74 (+44.49%)
Jul 29, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$86.80 $84.11▼ −3.10%▼ −3.82%$43.74 (−49.61%)
Showing 10 of 45

US Market Status

Market Closed — Opens Tue (16h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 10, 2026